Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy

BACKGROUND: Interferon (IFN)-based therapies could eradicate hepatitis C (HCV) and reduce the risk of hepatocellular carcinoma (HCC). However, HCC could still happen after sustained virological response (SVR). We aimed to develop a simple scoring system to predict the risk of HCC development among H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, K-C, Wu, Y-Y, Hung, C-H, Lu, S-N, Lee, C-M, Chiu, K-W, Tsai, M-C, Tseng, P-L, Huang, C-M, Cho, C-L, Chen, H-H, Hu, T-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817320/
https://www.ncbi.nlm.nih.gov/pubmed/24084770
http://dx.doi.org/10.1038/bjc.2013.564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817320/
https://www.ncbi.nlm.nih.gov/pubmed/24084770
http://dx.doi.org/10.1038/bjc.2013.564

Ejemplares similares